Global clinical reach PPD is a leading global clinical research business under Thermo Fisher, offering end-to-end services across early to late phase development, peri- and post-approval activities, and patient recruitment, indicating strong cross-therapy capabilities and potential for expanded client portfolios.

Bioanalytical expansion New Gothenburg laboratory expands bioanalytical and biomarker testing capabilities with GLP-compliant operations, presenting opportunities to upsell integrated lab services and faster turnarounds for global pharma and biotech sponsors.

Data driven advantage Strategic collaboration with HealthVerity to access large-scale real-world data sets enhances data-driven clinical development, enabling PPD to offer advanced evidence generation, observational study support, and real-world evidence capture as differentiators.

Technology stack depth Adoption of cloud, data integration, analytics, and search technologies (Azure, Elasticsearch, Tibco, Fluentd, etc.) supports scalable, efficient trial operations and robust data management, offering upsell opportunities for enhanced software-enabled services.

Strategic growth signals Recent facility expansion and collaboration announcements signal ongoing investment in capabilities and partnerships, creating conversations for multi-year outsourcing deals, capacity-backed pipeline growth, and expanded service scopes with current Thermo Fisher clients and new sponsors.